BRAIN Biotech AG (BNN.DE)
EUR 3.77
(-3.58%)
EUR 3.77
(-3.58%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 | -0.38 EUR | -31.03% |
| 2022 | -0.29 EUR | -26.09% |
| 2021 | -0.23 EUR | 52.08% |
| 2020 | -0.48 EUR | 17.24% |
| 2019 | -0.58 EUR | -26.09% |
| 2018 | -0.46 EUR | 20.69% |
| 2017 | -0.58 EUR | 40.21% |
| 2016 | -0.97 EUR | -115.56% |
| 2015 | -0.45 EUR | -12.5% |
| 2014 | -0.40 EUR | -14.29% |
| 2013 | -0.35 EUR | 27.08% |
| 2012 | -0.48 EUR | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 Q3 | -0.12 EUR | 42.86% |
| 2024 Q1 | -0.12 EUR | -60.0% |
| 2024 Q2 | -0.21 EUR | -75.0% |
| 2023 Q1 | -0.12 EUR | -1835.48% |
| 2023 Q4 | -0.08 EUR | 11.14% |
| 2023 FY | - EUR | -31.03% |
| 2023 Q3 | -0.08 EUR | 14.31% |
| 2023 Q2 | -0.10 EUR | 17.92% |
| 2022 Q2 | -0.06 EUR | 41.0% |
| 2022 FY | - EUR | -26.09% |
| 2022 Q4 | -0.01 EUR | 94.36% |
| 2022 Q3 | -0.11 EUR | -69.49% |
| 2022 Q1 | -0.11 EUR | -32.05% |
| 2021 Q1 | -0.17 EUR | 0.0% |
| 2021 FY | - EUR | 52.08% |
| 2021 Q2 | 0.10 EUR | 158.82% |
| 2021 Q4 | -0.08 EUR | 16.7% |
| 2021 Q3 | -0.10 EUR | -200.0% |
| 2020 Q4 | -0.17 EUR | -70.0% |
| 2020 Q1 | -0.13 EUR | 0.0% |
| 2020 Q3 | -0.10 EUR | 28.57% |
| 2020 Q2 | -0.14 EUR | -7.69% |
| 2020 FY | - EUR | 17.24% |
| 2019 FY | - EUR | -26.09% |
| 2019 Q4 | -0.13 EUR | 40.91% |
| 2019 Q3 | -0.22 EUR | -37.5% |
| 2019 Q1 | -0.07 EUR | -5.35% |
| 2019 Q2 | -0.16 EUR | -119.48% |
| 2018 Q2 | -0.13 EUR | 0.0% |
| 2018 FY | - EUR | 20.69% |
| 2018 Q4 | -0.07 EUR | 42.33% |
| 2018 Q3 | -0.12 EUR | 7.69% |
| 2018 Q1 | -0.13 EUR | -18.18% |
| 2017 Q3 | -0.10 EUR | -25.0% |
| 2017 Q1 | -0.28 EUR | 17.65% |
| 2017 Q2 | -0.08 EUR | 71.43% |
| 2017 FY | - EUR | 40.21% |
| 2017 Q4 | -0.11 EUR | -10.0% |
| 2016 Q4 | -0.34 EUR | -126.67% |
| 2016 FY | - EUR | -115.56% |
| 2016 Q3 | -0.15 EUR | 40.0% |
| 2016 Q2 | -0.25 EUR | -38.89% |
| 2016 Q1 | -0.18 EUR | -194.6% |
| 2015 Q1 | -0.06 EUR | 0.0% |
| 2015 FY | - EUR | -12.5% |
| 2015 Q2 | -0.15 EUR | -154.24% |
| 2015 Q3 | -0.15 EUR | 0.0% |
| 2015 Q4 | -0.06 EUR | 59.27% |
| 2014 FY | - EUR | -14.29% |
| 2013 FY | - EUR | 27.08% |
| 2012 FY | - EUR | 0.0% |
| Name | Eps | Eps Difference |
|---|---|---|
| BioNTech SE | 3.87 EUR | 109.819% |
| CureVac N.V. | -1.18 EUR | 67.797% |
| Biotest Aktiengesellschaft | 3.21 EUR | 111.838% |
| Biotest Aktiengesellschaft | 3.21 EUR | 111.838% |
| Formycon AG | 4.76 EUR | 107.983% |
| Heidelberg Pharma AG | -0.44 EUR | 13.636% |
| Medigene AG | -0.66 EUR | 42.424% |